-The Indian Express April 1 marked the third anniversary of the passage of the Right of Children for Free and Compulsory Education (RTE). There is little argument that the implementation of the RTE in these three years has been less than satisfactory. Deadlines for the enforcement of input norms - infrastructure, pupil-teacher ratios - have come and gone and potentially game-changing provisions, like 25 per cent reservation for economically weaker sections...

-The Hindu     A computerised database of ration card holders and purchases is a safeguard against diversion of PDS supplies but the process can be disruptive for beneficiaries The government has initiated an interesting pilot for the Public Distribution System (PDS) in East Godavari, Andhra Pradesh. When cardholders go to buy their PDS rations, their ration card number and UID (Unique Identification) number are punched into an "e-Point of Sale" (ePOS) machine. If...

-The Indian Express She was gangraped by 16 boys, nine of them juveniles. She was beaten, cut up and her genitals mutilated. She made it to hospital, but was sent home with first-aid. When she survived to fight, she ran into an indifferent Administration and influential accused. Schools denied her admission, and others mocked and threatened her. Chances are you haven't heard this 16-year-old's story. Three days after the brutal attack on...

-Outlook Bhubaneswar: The Comptroller and Auditor General (CAG) has found Odisha Government of extending undue benefits to South Korean steel major Posco in allotment of a piece of land in the state capital here. "The company was extended undue benefit in allotment of land disregarding zonal regulation and charging of premium at a reduced rate," the CAG in its latest report tabled in the Assembly yesterday said. The CAG observation was made based...

-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...